Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma × Rabeprazole × Clear all

NCT07076914 2025-07-22

PPI-PROTECT

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT04254471 2020-02-05

This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients

Phase 2/3 Unknown

Small Cell Lung Carcinoma